Interferon-α inhibits CD4 T cell responses to interleukin-7 and interleukin-2 and selectively interferes with Akt signaling

被引:14
|
作者
Nguyen, Thao P. [1 ]
Bazdar, Doug A. [1 ]
Mudd, Joseph C. [1 ]
Lederman, Michael M. [1 ]
Harding, Clifford V. [2 ]
Hardy, Gareth A. [2 ]
Sieg, Scott F. [1 ]
机构
[1] Case Western Reserve Univ, Dept Med, Div Infect Dis & HIV Med, Univ Hosp Case Med Ctr, Cleveland, OH 44106 USA
[2] Case Western Reserve Univ, Dept Pathol, Ctr AIDS Res, Univ Hosp Case Med Ctr, Cleveland, OH 44106 USA
基金
美国国家卫生研究院;
关键词
homeostatic proliferation; cytokines; RECOMBINANT HUMAN INTERLEUKIN-7; PHOSPHATIDYLINOSITOL; 3-KINASE; ANTIRETROVIRAL THERAPY; HIV-1; INFECTION; IL-7; PROMOTES; DNA-BINDING; IN-VIVO; RECEPTOR; ACTIVATION; KINASE;
D O I
10.1189/jlb.4A0714-345RR
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Persistent type I IFN production occurs during chronic viral infections, such as HIV disease. As type I IFNs have antiproliferative activity, it is possible that chronic exposure to these cytokines could adversely affect T cell homeostasis. We investigated the capacity of IFN-alpha to impair T cell proliferation induced by the homeostatic cytokine, IL-7, or another common g-chain cytokine, IL-2, in cells from healthy human donors. We found that IL-7-or IL-2-induced proliferation of CD4(+) T cells was partially inhibited in the presence of IFN-alpha. The CD4(+) T cells that were exposed to IFN-alpha also displayed attenuated induction of IL-2 and CD40L following TCR stimulation. Analyses of signaling pathways indicated that IL-7 and IL-2 induced a delayed and sustained P-Akt signal that lasted for several days and was partially inhibited by IFN-alpha. In contrast, IL-7-induced P-STAT5 was not affected by IFN-alpha. Furthermore, IFN-alpha had no detectable effect on P-Akt that was induced by the chemokine SDF-1. Both inhibitors of P-Akt and P-STAT5 blocked IL-7-induced T cell proliferation, confirming that both signaling pathways are important for IL-7-induced T cell proliferation. These results demonstrate that IFN-alpha can selectively inhibit cytokine-induced P-Akt as a potential mechanism to disrupt homeostasis of T lymphocytes.
引用
收藏
页码:1139 / 1146
页数:8
相关论文
共 50 条
  • [1] Type I interferon inhibits phosphorylation of AKT to impair T cell proliferation induced by interleukin-7
    Sieg, Scott
    Bazdar, Douglas
    JOURNAL OF IMMUNOLOGY, 2013, 190
  • [2] Administration of interleukin-7 increases CD4 T cells in idiopathic CD4 lymphocytopenia
    Sheikh, Virginia
    Porter, Brian O.
    DerSimonian, Rebecca
    Kovacs, Stephen B.
    Thompson, William L.
    Perez-Diez, Ainhoa
    Freeman, Alexandra F.
    Roby, Gregg
    Mican, JoAnn
    Pau, Alice
    Rupert, Adam
    Adelsberger, Joseph
    Higgins, Jeanette
    Bourgeois, Jeffrey S., Jr.
    Jensen, Stig M. R.
    Morcock, David R.
    Burbelo, Peter D.
    Osnos, Leah
    Maric, Irina
    Natarajan, Ven
    Croughs, Therese
    Yao, Michael D.
    Estes, Jacob D.
    Sereti, Irini
    BLOOD, 2016, 127 (08) : 977 - 988
  • [3] Interleukin-7 improves reconstitution of antiviral CD4 T cells
    Lu, H
    Zhao, Z
    Kalina, T
    Kiem, HP
    Storek, J
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2005, 11 (02) : 53 - 54
  • [4] Interleukin-7 improves reconstitution of antiviral CD4 T cells
    Lu, HL
    Zhao, Z
    Kalina, T
    Gillespy, T
    Liggitt, D
    Andrews, RG
    Maloney, DG
    Kiem, HP
    Storek, J
    CLINICAL IMMUNOLOGY, 2005, 114 (01) : 30 - 41
  • [5] CD4 AND CD8 REGULATE INTERLEUKIN-2 RESPONSES OF T-CELLS
    TAKAHASHI, K
    NAKATA, M
    TANAKA, T
    ADACHI, H
    NAKAUCHI, H
    YAGITA, H
    OKUMURA, K
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1992, 89 (12) : 5557 - 5561
  • [6] Interleukin-2, Interleukin-7, T cell-mediated autoimmunity, and N-glycosylation
    Grigorian, Ani
    Mkhikian, Haik
    Demetriou, Michael
    GLYCOBIOLOGY OF THE IMMUNE RESPONSE, 2012, 1253 : 49 - 57
  • [7] Interleukin-2, interferon-α and interleukin-2 plus interferon-α in renal cell carcinoma.: A randomized phase II trial
    Boccardo, F
    Rubagotti, A
    Canobbio, L
    Galligioni, E
    Sorio, R
    Lucenti, A
    Cognetti, F
    Ruggeri, E
    Landonio, G
    Baiocchi, C
    Besana, C
    Citterio, G
    De Rosa, M
    Calabresi, F
    TUMORI, 1998, 84 (05) : 534 - 539
  • [8] USE OF INTERLEUKIN-7, INTERLEUKIN-2, AND INTERFERON-GAMMA TO PROPAGATE CD4+ T-CELLS IN CULTURE WITH MAINTAINED ANTIGEN-SPECIFICITY
    COHEN, PA
    KIM, H
    FOWLER, DH
    GRESS, RE
    JAKOBSEN, MK
    ALEXANDER, RB
    MULE, JJ
    CARTER, C
    ROSENBERG, SA
    JOURNAL OF IMMUNOTHERAPY, 1993, 14 (03): : 242 - 252
  • [9] DIFFERENTIAL-EFFECTS OF INTERLEUKIN-2 AND INTERLEUKIN-7 ON THE INDUCTION OF CD4 AND CD8 EXPRESSION BY DOUBLE-NEGATIVE HUMAN THYMOCYTES
    HE, W
    KABELITZ, D
    SCANDINAVIAN JOURNAL OF IMMUNOLOGY, 1995, 41 (03) : 309 - 312
  • [10] Recombinant interferon-alpha selectively inhibits the production interleukin-5 by human CD4(+) T cells
    Schandene, L
    DelPrete, GF
    Cogan, E
    Stordeur, P
    Crusiaux, A
    Kennes, B
    Romagnani, S
    Goldman, M
    JOURNAL OF CLINICAL INVESTIGATION, 1996, 97 (02): : 309 - 315